Hemophilia Advisory Board

Mark A. Kay, MD, Ph.D

Dennis Farrey Family Professor in Department of Pediatrics, Professor of Genetics, Stanford University

Prof. Kay is the Dennis Farrey Family Professor and the Associate Chair for Basic Research in the Department of Pediatrics, Professor of Genetics and the Head of the Division of Human Gene Therapy at the Stanford University’s School of Medicine. 

Kimo Stine, MD

Professor of Pediatrics and Medical Director of the Arkansas Center of Bleeding Disorders at Arkansas Children’s Hospital

Prof. Stine graduated from the University of Kansas and completed his pediatric residency at the Kansas University Medical Center in Kansas City, Kansas. He completed his training in Pediatric Hematology Oncology at Duke University. 

*** involved in Sangamo and UniQure clinical trials

Annette Von Drygalski, MD, PharmD, RMSK

Professor of Clinical Medicine, Director of the Hemophilia and Thrombosis Treatment Center at UCSD

Prof. von Drygalski completed fellowship training in hematology/oncology at UC San Diego School of Medicine. She earned her medical and pharmaceutical doctorates from the Ludwig Maximilian University in Munich, Germany.

*** involved in UniQure clinical trial

Steven Pipe, MD

Professor of Pediatrics and Pathology, Medical Director of the Pediatric Hemophilia and Coagulation Disorders Program at the University of Michigan

Prof. Pipe completed his undergraduate medical training at the University of Toronto, Ontario, Canada, and his pediatric training at McMaster University in Hamilton, Ontario. His pediatric hematology and oncology training was completed at the University of Michigan.

*** PI in UniQure clinical trial, involved in BioMarin clinical trial

Gili Kenet, MD

Professor and Chair of the Haematology department at the Sackler Medical School, Tel Aviv University

Prof. Kenet received her Medical Degree from the Hebrew University in Jerusalem. She is Director of the Israel National Hemophilia Center in Tel Hashomer, Israel.

*** involved in BioMarin clinical trial